Thomas Kerr

Jason Wittes

- Zimmer Biomet Holdings, Inc. completed its acquisition of **Monogram Technologies Inc.** on **October 7, 2025**.  **[1769759_0001104659-25-097530_tm2527971d1_ex99-1.htm:0]** **[1769759_0001104659-25-097530_tm2527971d1_8k.htm:0]** 
- Each outstanding share of Monogram common stock was converted into the right to receive **$4.04 in cash** and non-tradeable contingent value rights (CVRs).  **[1769759_0001104659-25-097530_tm2527971d1_ex99-1.htm:0]** **[1769759_0001104659-25-097530_tm2527971d1_8k.htm:1]** 
- The CVRs entitle holders to receive up to an additional **$12.37 in cash** if certain product development, regulatory, and revenue milestones are achieved through **2030**.  **[1769759_0001104659-25-097530_tm2527971d1_ex99-1.htm:0]** 
- Monogram shares ceased trading on NASDAQ prior to market opening on **October 7, 2025**, and will be delisted.  **[1769759_0001104659-25-097530_tm2527971d1_ex99-1.htm:0]**

Monogram Technologies Inc. Acquisition Completed by Zimmer Biomet

- Monogram Technologies Inc. is urging its **registered stockholders** to vote on the proposed **acquisition by Zimmer Biomet**.  **[1769759_0001104659-25-085618_tm2524795d1_ex99-1.htm:0]** 
- The special meeting for stockholders to approve the acquisition is scheduled for **September 30, 2025**.  **[1769759_0001104659-25-085618_tm2524795d1_ex99-1.htm:0]** **[1769759_0001104659-25-085618_tm2524795d1_ex99-3.htm:0]** **[1769759_0001104659-25-085618_tm2524795d1_ex99-4.htm:0]** 
- The company commenced distributing texts and emails on **August 29, 2025**, to alert stockholders about the meeting and encourage voting.  **[1769759_0001104659-25-085618_tm2524795d1_ex99-1.htm:0]** **[1769759_0001104659-25-085618_tm2524795d1_8k.htm:1]** 
- The Board of Directors **recommends voting FOR** the Agreement and Plan of Merger.  **[1769759_0001104659-25-085618_tm2524795d1_ex99-3.htm:0]** **[1769759_0001104659-25-085618_tm2524795d1_ex99-4.htm:0]**

Monogram Technologies (MGRM)